Dhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve THE MEETING IS BE HELD ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhanvantri Jeevan Rekha Ltd has informed BSE about a Board of Directors meeting scheduled for Friday, 14th November 2025 at 03:00 PM. The main agenda is to consider and approve the unaudited financial results along with the Limited Review Report of the Auditors for the quarter ended 30th September 2025 (Q2 FY26). The trading window for dealing in the company's equity shares has been closed from 1st October 2025 and will remain closed until 48 hours after the results are made public. The intimation was signed by Ritika Bhandari, Company Secretary and Compliance Officer.
This is a routine regulatory filing ahead of quarterly results and does not directly impact shareholders. Investors should watch for the actual Q2 FY26 numbers, which will be released after the board meeting on 14th November 2025, as they will indicate the hospital's financial performance for the quarter.